Article Impact Level: HIGH Data Quality: STRONG Summary of JAMA Internal Medicine https://doi.org/10.1001/jamainternmed.2026.5899 Dr. Chengyi Zheng et al.
Points
- Kaiser Permanente Southern California researchers analyzed over one point eight million vaccinations administered to one point four million adults to compare shoulder injury rates between COVID nineteen and influenza vaccines.
- Investigators identified one hundred ten shoulder injury cases following COVID nineteen vaccinations and one hundred forty two cases following influenza vaccinations representing exceptionally low overall absolute incidence rates.
- Adjusted statistical analyses demonstrated that COVID nineteen vaccination was associated with a sixty three percent higher relative risk translating to roughly seven additional cases per one hundred thousand doses.
- Subgroup evaluation among adults aged sixty five years and older found no statistically significant difference in shoulder injury rates between COVID nineteen and high dose influenza vaccinations.
- Authors concluded that proper intramuscular injection techniques remain essential to minimize local trauma while emphasizing that proven vaccination benefits substantially outweigh the minimal absolute risk of shoulder injury.
Summary
This large-scale retrospective cohort study evaluated the comparative incidence of shoulder injury related to vaccine administration (SIRVA) following COVID-19 versus influenza vaccinations in adult patients. Published in JAMA Internal Medicine by researchers from Kaiser Permanente Southern California, the investigation analyzed clinical records for over 1.8 million vaccinations administered to 1.4 million adults between August 2023 and April 2024. Defining SIRVA as unexplained shoulder symptoms originating in the vaccinated arm within 7 days of injection and persisting for at least 30 days, the study sought to quantify absolute and relative risks across adult age groups, particularly given potential age-related anatomical vulnerabilities in older populations.
Investigators identified 110 SIRVA cases across 596,614 COVID-19 vaccinations (0.018%) and 142 cases across 1.2 million influenza vaccinations (0.012%), corresponding to incidence rates of 1.8 and 1.15 cases per 10,000 vaccinations, respectively. After adjusting for confounding variables, COVID-19 vaccination was associated with a 63% higher relative risk of SIRVA compared with influenza vaccination, representing approximately 7 additional cases per 100,000 doses. Subgroup analysis of adults aged 65 years and older revealed SIRVA incidences of 2.1 cases per 10,000 COVID-19 vaccinations versus 1.6 cases per 10,000 high-dose influenza vaccinations, a difference that did not reach statistical significance. Most COVID-19 doses administered in the cohort were Pfizer/BioNTech mRNA vaccines.
The authors conclude that while COVID-19 vaccination carries a modestly elevated relative risk of SIRVA compared to standard influenza vaccination, the absolute risk remains exceedingly low for both immunizations. Adhering strictly to proper intramuscular deltoid injection techniques is essential to prevent inadvertent subacromial or intra-articular administration, though the small risk of local shoulder complications is substantially outweighed by the proven benefits of vaccination in preventing severe disease and hospitalization.
Link to the article: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2856238#google_vignette
References
Zheng, C., Qian, L., Sy, L. S., Goodwin, G. V., Yeh, M., Navarro, R. A., Asamura, D. T., Ryan, D. S., Duffy, J., Nelson, J. C., Lewin, B. J., & Tseng, H. F. (2026). Risk of shoulder injury related to vaccine administration for covid-19 and influenza vaccinations. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.5899
